Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2022 / Jul / Conditions for Success
Retina Research & Innovations

Conditions for Success

Can we use stem cells to regenerate the retina without direct transplantation?

By Geoffrey Potjewyd 7/8/2022 2 min read

Share

Credit: Image sourced from Shutterstock.com Caption: Bottles of culture medium that are used to feed cells.

It goes without saying that the tissues of the eye are made of a variety of cell types, and each type benefits the others that share its home. For example, the eye’s glial, endothelial, and retinal ganglion cells all secrete chemicals that are beneficial to neurons and the retina. So why not look at using this cocktail of nice stuff to benefit the eye?

This is what researchers from Fundación Hospital de Jove in Asturias, Spain, have investigated – finding that cell medium conditioned by human uterine cervical stem cells (hUCESCs – think of a stem cell medium broth with the stem cells removed) actually regulates both oxidative stress and angiogenesis in retinal pigment epithelium (RPE) cells (1). The regenerative effects of stem cells are well known, so it stands to reason that the cocktail of secretions from these cells could have similar benefits in the retina.

Oxidative stress is a major contributor to the tissue damage and abnormal vascularization in a number of retinal diseases, including diabetic retinopathy, AMD, and uveitis. Using conditioned medium from hUCESCs to create an “energy drink” for RPE cells could offer the positive effects of stem cells without having to transplant tissue into the eye. Researching the secretome of hUCESCs to isolate biochemical pathways beneficial to the RPE could also open avenues for novel drug targets and even the repurposing of drugs for this purpose.

Energy drink for cells
 

For those who have never been in the lab, cell medium is what researchers feed their cells – hopefully keeping them happy and, in this case, providing proteins and chemicals that can help RPE cells in trouble. The majority of cell media are rich in glucose, salt, and all things needed for the maintenance and growth of hUCESCs. This sugary “energy drink” aimed at cells will often have phenol red in its mixture, enabling researchers to see pH changes in their cell-medium mix – but don’t be fooled by the cherry-like color; this “forbidden drink” should only be consumed by our cellular friends. The researchers create the conditioned medium used for their experiments by feeding hUCESCs for 48 hours before removing the cell medium with all its secreted goodies and treating the RPE cells. The hUCESCs themselves were obtained via cervical smears during routine gynecological checkups at the Fundación Hospital de Jove.

References

  1. N Eiro et al., Ophthalmic Res, [Online ahead of print] (2022). PMID: 35584686.

About the Author(s)

Geoffrey Potjewyd

The lion’s share of my PhD was spent in the lab, and though I mostly enjoyed it (mostly), what I particularly liked was the opportunity to learn about the latest breakthroughs in research. Communicating science to a wider audience allows me to scratch that itch without working all week only to find my stem cell culture has given up the ghost on the Friday (I’m not bitter). Fortunately for me, it turns out writing is actually fun – so by working for Texere I get to do it every day, whilst still being an active member of the clinical and research community.

More Articles by Geoffrey Potjewyd

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: